RS51183B - Farmaceutske kompozicije koje sadrže diaminooksidazu - Google Patents
Farmaceutske kompozicije koje sadrže diaminooksidazuInfo
- Publication number
- RS51183B RS51183B RSP-2009/0371A RSP20090371A RS51183B RS 51183 B RS51183 B RS 51183B RS P20090371 A RSP20090371 A RS P20090371A RS 51183 B RS51183 B RS 51183B
- Authority
- RS
- Serbia
- Prior art keywords
- diaminooxidase
- pharmaceutical compositions
- containing pharmaceutical
- antiallergic
- dermatological
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/06—Enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
- A23L29/262—Cellulose; Derivatives thereof, e.g. ethers
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/44—Oxidoreductases (1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/44—Oxidoreductases (1)
- A61K38/443—Oxidoreductases (1) acting on CH-OH groups as donors, e.g. glucose oxidase, lactate dehydrogenase (1.1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y104/00—Oxidoreductases acting on the CH-NH2 group of donors (1.4)
- C12Y104/03—Oxidoreductases acting on the CH-NH2 group of donors (1.4) with oxygen as acceptor (1.4.3)
- C12Y104/03006—Amine oxidase (copper-containing)(1.4.3.6)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Mycology (AREA)
- Pulmonology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Dermatology (AREA)
- Dispersion Chemistry (AREA)
- Biophysics (AREA)
- Otolaryngology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Toxicology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Farmaceutska kompozicija za lečenje histaminom izazvanih bolesti, koja sadrži diaminooksidazu, naznačena time, što je kompozicija farmaceutski oblik koji je otporan na dejstvo želudačne kiseline za oralno ili peroralno davanje.Prijava sadrži još 13 patentnih zahteva.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT0115004A AT502098B8 (de) | 2004-07-07 | 2004-07-07 | Diaminooxidase-hältige zusammensetzung |
PCT/EP2005/053234 WO2006003213A1 (de) | 2004-07-07 | 2005-07-06 | Pharmazeutische zusammensetzungen, die diaminooxidase enthalten |
Publications (1)
Publication Number | Publication Date |
---|---|
RS51183B true RS51183B (sr) | 2010-10-31 |
Family
ID=34971770
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RSP-2009/0371A RS51183B (sr) | 2004-07-07 | 2005-07-06 | Farmaceutske kompozicije koje sadrže diaminooksidazu |
Country Status (20)
Country | Link |
---|---|
US (3) | US20080193491A1 (sr) |
EP (2) | EP1782824B1 (sr) |
JP (1) | JP4959558B2 (sr) |
KR (1) | KR101367232B1 (sr) |
CN (1) | CN1980689A (sr) |
AT (4) | AT502098B8 (sr) |
AU (1) | AU2005259167B2 (sr) |
BR (1) | BRPI0513133B1 (sr) |
CA (1) | CA2571463C (sr) |
CY (1) | CY1109351T1 (sr) |
DE (2) | DE502005009568D1 (sr) |
DK (1) | DK1763363T3 (sr) |
ES (1) | ES2326421T3 (sr) |
HR (1) | HRP20090447T1 (sr) |
MX (1) | MXPA06015036A (sr) |
PL (1) | PL1763363T3 (sr) |
PT (1) | PT1763363E (sr) |
RS (1) | RS51183B (sr) |
SI (1) | SI1763363T1 (sr) |
WO (1) | WO2006003213A1 (sr) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20160024481A1 (en) * | 2011-03-18 | 2016-01-28 | Dr Healthcare España, S.L. | Topical compositions comprising diaminooxidase for the treatment or prevention of diseases associated with high histamine levels which involve an increase in pain |
ES2388395B1 (es) * | 2011-03-18 | 2013-10-01 | Dr Healthcare España, S. L. | Uso de la diaminooxidasa para el tratamiento o la prevención de la fibromialgia o la fatiga crónica. |
ES2388166B1 (es) * | 2011-03-18 | 2013-10-01 | Dr Healthcare España, S. L. | Alimentos funcionales que contienen diaminooxidasa y sus usos. |
ES2387973B1 (es) * | 2011-03-18 | 2013-10-01 | Dr Healthcare España, S. L. | Composiciones tópicas que contienen diaminooxidasa para el tratamiento o la prevención de enfermedades asociadas a un nivel de histamina elevada que comportan un aumento del dolor. |
US20170020993A1 (en) * | 2011-03-18 | 2017-01-26 | Dr Healthcare España, S.L. | Composition comprising diamine oxidase for use in the treatment or prevention of fibromyalgia or chronic fatigue syndrome |
ES2388515B1 (es) * | 2011-03-18 | 2013-10-01 | Dr Healthcare España, S. L. | Uso de la diaminooxidasa para la prevención de los síntomas de la resaca. |
ES2703513T3 (es) | 2011-04-07 | 2019-03-11 | Histapharm Inc | Composiciones enzimáticas orales para administración intestinal |
ES2426539B1 (es) | 2012-04-18 | 2014-09-09 | Dr Healthcare España, S. L. | Uso de la diaminooxidasa para el tratamiento o la prevención del trastorno por deficit de atencion con hiperactividad (adhd) |
EP3728061A4 (en) * | 2017-12-21 | 2021-09-08 | Pepsico Inc | MULTI-INGREDIENT POP-UP DRINK CAPSULE FOR PREPARING A DRINK |
SG11202107659SA (en) | 2019-02-19 | 2021-09-29 | Univ Wien Med | New recombinant diamine oxidase and its use for the treatment of diseases characterized by excess histamine |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB479487A (en) * | 1935-08-01 | 1938-02-04 | Ig Farbenindustrie Ag | Manufacture of stable therapeutic products from intestinal mucous membrane |
NL6815177A (sr) * | 1968-10-24 | 1970-04-28 | ||
GB1318884A (en) * | 1969-07-29 | 1973-05-31 | Hydrovane Compressor | Rotary compressors |
FR2101095A1 (en) * | 1970-08-20 | 1972-03-31 | Merieux Inst | Diamine oxidase from human placenta - for treatment of hyperhistamina |
US3639579A (en) * | 1970-12-10 | 1972-02-01 | Matthew C Urbin | Pharmaceutical preparation |
FR2215944A1 (en) * | 1973-02-01 | 1974-08-30 | Bellon Labor Sa Roger | Extracts of human placenta - free of proteases, and contg. histaminase, kininases and monoamine-oxidases for treating allergies |
FR2529463B1 (fr) * | 1982-07-05 | 1986-01-10 | Centre Nat Rech Scient | Procede et dispositif pour l'encapsulation dans les erythrocytes d'au moins une substance a activite biologique, notamment des effecteurs allosteriques de l'hemoglobine et erythrocytes ainsi obtenus |
GB8319540D0 (en) * | 1983-07-20 | 1983-08-24 | Bovril Ltd | Amine removal |
US4725540A (en) * | 1984-07-09 | 1988-02-16 | Emil Underberg | Process for the preparation of amine-oxidase containing material, so produced amine-oxidase containing material |
US5270033A (en) * | 1991-11-25 | 1993-12-14 | Montgomery Robert E | Antimicrobial composition and method of making same |
WO2000032172A1 (en) * | 1998-11-27 | 2000-06-08 | Kanji Takada | An oral formulation for gastrointestinal drug delivery |
JP4839506B2 (ja) | 2000-04-28 | 2011-12-21 | ダイキン工業株式会社 | ドライエッチング方法 |
JP4592041B2 (ja) * | 2000-11-24 | 2010-12-01 | 株式会社Nrlファーマ | 生活の質を改善する新規食品の製造法および用途 |
IT1317067B1 (it) * | 2000-11-29 | 2003-05-26 | Univ Roma | Istaminasi di origine vegetale nel trattamento dello shock allergico esettico e nell'asma allergico. |
WO2002066669A1 (en) * | 2001-02-23 | 2002-08-29 | Biovitrum Ab | Method for purification of soluble ssao |
JP2003212773A (ja) * | 2002-01-04 | 2003-07-30 | Oramon Arzneimittel Gmbh | セチリジン及びロラタジンの局所医薬組成物 |
DE10239029A1 (de) * | 2002-08-21 | 2004-03-04 | Coty B.V. | Kosmetische und dermatologische Zubereitung mit Proteinen zur Hautaufhellung |
JP2004167178A (ja) * | 2002-11-15 | 2004-06-17 | Masashi Takahashi | タン白質の経口投与法 |
-
2004
- 2004-07-07 AT AT0115004A patent/AT502098B8/de not_active IP Right Cessation
-
2005
- 2005-07-06 US US11/571,732 patent/US20080193491A1/en not_active Abandoned
- 2005-07-06 ES ES05758617T patent/ES2326421T3/es active Active
- 2005-07-06 MX MXPA06015036A patent/MXPA06015036A/es active IP Right Grant
- 2005-07-06 BR BRPI0513133A patent/BRPI0513133B1/pt not_active IP Right Cessation
- 2005-07-06 AU AU2005259167A patent/AU2005259167B2/en not_active Ceased
- 2005-07-06 SI SI200530749T patent/SI1763363T1/sl unknown
- 2005-07-06 AT AT07101239T patent/ATE467423T1/de active
- 2005-07-06 RS RSP-2009/0371A patent/RS51183B/sr unknown
- 2005-07-06 PL PL05758617T patent/PL1763363T3/pl unknown
- 2005-07-06 CN CNA2005800227917A patent/CN1980689A/zh active Pending
- 2005-07-06 PT PT05758617T patent/PT1763363E/pt unknown
- 2005-07-06 CA CA2571463A patent/CA2571463C/en active Active
- 2005-07-06 WO PCT/EP2005/053234 patent/WO2006003213A1/de active Application Filing
- 2005-07-06 DK DK05758617T patent/DK1763363T3/da active
- 2005-07-06 EP EP07101239A patent/EP1782824B1/de active Active
- 2005-07-06 DE DE502005009568T patent/DE502005009568D1/de active Active
- 2005-07-06 JP JP2007519799A patent/JP4959558B2/ja not_active Expired - Fee Related
- 2005-07-06 EP EP05758617A patent/EP1763363B1/de active Active
- 2005-07-06 AT AT05758617T patent/ATE432710T1/de active
- 2005-07-06 DE DE502005007425T patent/DE502005007425D1/de active Active
- 2005-07-06 KR KR1020077002826A patent/KR101367232B1/ko not_active IP Right Cessation
-
2006
- 2006-09-29 AT AT0162706A patent/AT503070B1/de active
-
2009
- 2009-08-20 HR HR20090447T patent/HRP20090447T1/hr unknown
- 2009-08-28 CY CY20091100902T patent/CY1109351T1/el unknown
-
2010
- 2010-08-24 US US12/862,379 patent/US8716244B2/en active Active
-
2014
- 2014-04-04 US US14/245,358 patent/US9364437B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1109351T1 (el) | Φαρμακευτικες συνθεσεις που περιεχουν διαμινοοξειδαση | |
WO2004021968A3 (en) | Solution for ungual application | |
WO2009074735A8 (fr) | Utilisation d'un nouvel agent naturel dans des compositions cosmetiques | |
WO2004014143A8 (en) | Compositions and process for delivering an additive | |
TW200637522A (en) | Skin treatment articles and methods | |
WO2009040420A3 (en) | Use of a monoterpene to increase tissue repair | |
MX2008003422A (es) | Composiciones que comprenden al menos un derivado de acido naftoico y al menos un compuesto de tipo polimero de poliuretano o derivados del mismo, procesos de preparacion y composiciones que comprenden al menos un derivado de acido naftoico y al meno | |
HK1112721A1 (en) | Tissue disruption treatment and composition for use thereof | |
WO2006013261A3 (fr) | Utilisation de fibroblastes gingivaux en therapie cellulaire vasculaire. | |
PL1893237T3 (pl) | Kompozycja farmaceutyczna zawierająca elastomer poliorganosiloksanowy i solubilizowany składnik aktywny | |
WO2005121329A3 (en) | Method for ameliorating an inflammatory skin condition | |
WO2008004165A3 (en) | Use of c-glycoside derivatives as pro-desquamating active agents | |
PL1868631T3 (pl) | Zastosowanie związków indukujących syntezę białek SIRT przy lub dla otrzymywania kompozycji kosmetycznej lub farmaceutycznej | |
WO2007025229A3 (en) | Compositions and their uses directed to hsp27 | |
WO2007029188A3 (en) | Method of using fabric care compositions to achieve a synergistic odor benefit | |
MXPA05014184A (es) | Utilizacion de acido hialuronico para la preparacion de composiciones para el tratamiento de aftas en la cavidad oral. | |
WO2003105751A3 (en) | NEW CURCUMIN DERIVATIVES | |
ITBO20020544A1 (it) | Uso di farine vegetali come agenti biotossici ad azione ammendante. | |
WO2006122721A3 (de) | Verwendung von peroxidzersetzern in kosmetischen und pharmazeutischen mitteln zur behandlung der haut | |
TW200505408A (en) | Agent for preventing and/or treating tissue disruption-accompanied diseases | |
WO2004097009A3 (en) | METHOD TO IDENTIFY AGENTS THAT ACTIVATE OR INHIBIT IKKi | |
WO2006018551A8 (fr) | Nouveau peptide et composition pharmaceutique le contenant | |
HK1111924A1 (en) | Depigmenting or brightening cosmetic composition comprising at least one oxazolin as an active ingredient | |
WO2007003773A3 (fr) | Utilisation d'un extrait de levure en tant qu'agent actif inducteur de la synthese des proteines sirt dans les cellules de la peau | |
PL2100592T3 (pl) | Kosmetyk o działaniu przeciw starzeniu |